On February 3, the final workshop of the European Smart4Fabry project will be held. Smart4Fabry is an initiative whose objective is to obtain a new GLA nanoformulation to address Fabry disease, achieving relevant improvements on the efficacy and tolerance of the treatments based on enzyme replacement therapies. Our technology transfer director Alba Córdoba will lead the session dealing with Production Optimization and Scale-up of the nanoformulation and our CEO Santi Sala will contribute to the final round table.

Online venue:

Further relevant information regarding the event will be provided on https://smart4fabry.eu/

Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream